Logo
Our Advantage Industries We Support Our Team
  • Our Advantage
  • Take Action
    • Activism Defense
    • Hostile M&A Defense
    • Shareholder Activism
    • Activism Preparedness
    • Corporate Governance & Proxy Advisory Consulting
  • Industries We Support
  • Our Team
  • Resources
    • Activism Screener Tool
    • Media
    • Case Studies

Category: Allergan

Back to All
Featured Image
View Resource

Allergan Escapes Valeant's Pursuit, Agreeing to Be Bought by Actavis - The New York Times

Allergan November 17, 2014
Featured Image
View Resource

Allergan Seeks to Discredit Would-Be Buyer Valeant - The New York Times

Allergan May 27, 2014
Footer Logo
  • HOME
  • OUR ADVANTAGE
  • ACTIVISM DEFENSE
  • HOSTILE M&A DEFENSE
  • SHAREHOLDER INSIGHTS & INTELLIGENCE
  • ACTIVISM PREPAREDNESS
  • CORPORATE GOVERNANCE &
    PROXY ADVISORY CONSULTING
  • INDUSTRIES WE SUPPORT
  • OUR TEAM
  • ACTIVISM SCREENER TOOL
  • MEDIA
  • CONTACT

Contact

  • 555 12th Street NW
    Suite 700
    Washington, DC 20004
  • ftiactivism@fticonsulting.com
Twitter @FTIactivism
© FTI Consulting | Activism and M&A Solutions